23 results
Thumbnail

D2.471 - Efficacy of omalizumab in the treatment of chronic spontaneous urticaria in children

Thumbnail

D2.473 - Omalizumab as adjuvant therapy in drug desensitization to chemotherapy- a single Center experience

Thumbnail

D2.475 - Treatment delay and likelihood of remission on omalizumab in chronic spontaneous urticaria: a real-world observational study

Thumbnail

D2.464 - Stapokibart (anti–IL-4Rα monoclonal antibody) across type 2 inflammatory diseases in routine practice: a three-case series of severe atopic dermatitis, chronic urticaria with rhinosinusitis, and immune-related bullous pemphigoid

Thumbnail

D2.465 - Omalizumab Enhances Safety and Supports Completion of Oral Immunotherapy in High-Risk Patients

Thumbnail

D2.466 - More options for the treatment of Chronic Spontaneous Urticaria: Tezepelumab

Thumbnail

D2.467 - Management of Netherton syndrome and hereditary angioedema with concurrent biologic therapy: a novel case

Thumbnail

D2.468 - Real-world effectiveness and safety of dupilumab in pediatric atopic dermatitis: a retrospective cohort study

Thumbnail

D2.469 - Pre-switch perceptions of omalizumab biosimilar prefilled pen in pediatric allergy: a cross-sectional survey

Thumbnail

D2.470 - Potential Clinical and Laboratory Biomarkers for Predicting Omalizumab Response in Chronic Spontaneous Urticaria

Thumbnail

D2.472 - Immunology Innovation Program: Developing Antibodies Against Novel Targets Through Co-creation

Thumbnail

D2.474 - Use of Dupilumab as treatment for Eosinophilic Enteritis: a case report

Thumbnail

D2.476 - Mepolizumab Enables Meaningful Real-World Improvements in SNOT-22 and Smell Dysfunction in Chronic Rhinosinusitis with Nasal Polyps: Post Hoc Analysis of REALITI-N at 3 and 6 Months

Thumbnail

- D3.509 - Predicting Fungal and Bacterial Bioaerosol Concentrations Across Distinct Building Types: A Generalized Additive Model and Machine Learning Framework

Thumbnail

- D3.515 - PM2.5 exposure shapes monocyte and T cell immune reprogramming in allergic airway disease

Thumbnail

- D3.516 - Airborne pollen where and when it should not exist – Towards ‘allergy-safe’ environments or adopting a Planetary Health approach?

Thumbnail

- D3.517 - Design of an AI-Based Decision Support System for Field-Tailored Personal Protective Equipment Using Multi-Layer Protective Composites

Thumbnail

- D3.518 - Environmentally relevant irregular polystyrene particles exert stronger biological effects than spherical model particles in human bronchial smooth muscle cells

Thumbnail

- D3.510 - Correlation between Emergency visits and Platanus ssp pollen levels in a child population

Thumbnail

- D3.511 - Correlation between Emergency visits and Platanus ssp pollen levels